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ABSTRACT Staphylococcus aureus must rapidly adapt to a variety of carbon and
nitrogen sources during invasion of a host. Within a staphylococcal abscess, pre-
ferred carbon sources such as glucose are limiting, suggesting that S. aureus sur-
vives through the catabolism of secondary carbon sources. S. aureus encodes
pathways to catabolize multiple amino acids, including those that generate pyru-
vate, 2-oxoglutarate, and oxaloacetate. To assess amino acid catabolism, S. au-
reus JE2 and mutants were grown in complete defined medium containing
18 amino acids but lacking glucose (CDM). A mutation in the gudB gene, coding
for glutamate dehydrogenase, which generates 2-oxoglutarate from glutamate,
significantly reduced growth in CDM, suggesting that glutamate and those
amino acids generating glutamate, particularly proline, serve as the major carbon
source in this medium. Nuclear magnetic resonance (NMR) studies confirmed this
supposition. Furthermore, a mutation in the ackA gene, coding for acetate ki-
nase, also abrogated growth of JE2 in CDM, suggesting that ATP production
from pyruvate-producing amino acids is also critical for growth. In addition, al-
though a functional respiratory chain was absolutely required for growth, the ox-
ygen consumption rate and intracellular ATP concentration were significantly
lower during growth in CDM than during growth in glucose-containing media.
Finally, transcriptional analyses demonstrated that expression levels of genes
coding for the enzymes that synthesize glutamate from proline, arginine, and
histidine are repressed by CcpA and carbon catabolite repression. These data
show that pathways important for glutamate catabolism or ATP generation via
Pta/AckA are important for growth in niches where glucose is not abundant,
such as abscesses within skin and soft tissue infections.
IMPORTANCE S. aureus is a significant cause of both morbidity and mortality world-
wide. This bacterium causes infections in a wide variety of organ systems, the most
common being skin and soft tissue. Within a staphylococcal abscess, levels of glu-
cose, a preferred carbon source, are limited due to the host immune response.
Therefore, S. aureus must utilize other available carbon sources such as amino acids
or peptides to proliferate. Our results show that glutamate and amino acids that
serve as substrates for glutamate synthesis, particularly proline, function as major
carbon sources during growth, whereas other amino acids that generate pyruvate
are important for ATP synthesis via substrate-level phosphorylation in the Pta-AckA
pathway. Our data support a model whereby certain amino acid catabolic pathways,
and acquisition of those particular amino acids, are crucial for growth in niches
where glucose is not abundant.
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Staphylococcus aureus has the ability to establish infections in a wide variety ofmetabolic niches within the human host, including, among others, the heart, bone,
kidney, blood, and soft tissue. Significant advances have been made in the study of
bacterial virulence factors and their functions in human disease and infection of these
various organ systems. However, we have only begun to study how particular carbon
and nitrogen sources that are available to S. aureus in specific host niches affect
virulence factor expression and subsequent invasion, metastasis, or quiescence. As
these metabolic pathways are required for bacterial proliferation within the host,
knowledge of these pathways may reveal novel avenues for drug development.
A critical component of the innate immune response is the synthesis of nitric oxide
(NO) by inducible nitric oxide synthase (iNOS) within activated phagocytes (1). Nitric
oxide has wide-ranging effects on bacterial cells, including the disruption of lipid
biosynthesis, central metabolism, respiration, and DNA replication (2). Data from an
evolving model demonstrate that, in contrast to other staphylococcal species, S. aureus
has the ability to grow under NO stress conditions by fermenting glucose via lactate
dehydrogenase, generating lactate, and facilitating NAD regeneration to maintain
glycolytic flux and redox balance (3–7). Under NO stress conditions, glycolysis is an
essential process, as a mutation in the glycolytic enzyme pyruvate kinase (coded for by
pyk) severely inhibits initiation of abscess formation in a skin and soft tissue murine
model (7). Indeed, inhibitors of pyruvate kinase have proved promising against S. au-
reus and other Gram-positive pathogens (8–11).
Following invasion of host tissue, S. aureus replicates in abscess communities that
are encapsulated within fibrin deposits and infiltrating immune cells (12). Much recent
work has led to an overarching view of abscess formation, including the definition of
essential virulence factors such as coagulase, von Willebrand factor, ClfA, FnbpA, and
FnbpB (13). As the abscess matures within the fibrin wall, the center includes a large
cluster of viable cells called the staphylococcal abscess community (12, 14). It is
hypothesized that these niches have low concentrations of NO, allowing respiratory
activity (5, 15); however, it is predicted that S. aureus must grow on nonpreferred
carbon sources, as glucose is not abundant (6, 16). Indeed, S. aureus lacks the ability to
utilize phospholipids, triglycerides, and potentially other short-chain fatty acids as
carbon sources due to the lack of both -oxidation and glyoxylate shunt pathways.
Therefore, other carbon sources that are available include lactate, excreted from
S. aureus during fermentative growth, as well as peptides and free amino acids. Recent
work from Spahich and colleagues showed that the addition of lactate plus peptides
supports growth of S. aureus under conditions of low NO stress (6). Growth under these
conditions was dependent upon the presence of lactate quinone oxidoreductase (Lqo;
coded for by lqo), which assimilates lactate in an NAD-independent manner and
requires an electron acceptor such as oxygen or nitrate (4). Importantly, growth under
these conditions also required peptides to serve as a carbon source to facilitate
gluconeogenesis.
To date, little has been known about amino acid catabolism in S. aureus; however,
bioinformatics analysis suggests that pathways are present to catabolize multiple
amino acids, including those that generate pyruvate, 2-oxoglutarate, and oxaloacetate
(see Table S1 in the supplemental material). Although it is unclear in which microniches
amino acid/peptide catabolism is important, it has been presumed that S. aureus
utilizes peptides/amino acids as carbon sources as it encodes multiple oligopeptide
permeases and free amino acid transporters (17–19). In addition, S. aureus encodes
metalloenzyme, serine, and papain-like cysteine proteases that have the ability to
degrade host proteins (20). We have recently understood that at least some of these
amino acid catabolic pathways, such as those linking arginine and proline, are re-
pressed by carbon catabolite repression (via CcpA) and are induced only when S. aureus
is growing on nonpreferred carbon sources (21–23). Thus, a S. aureus ccpA mutant
interconverts arginine and proline via an intact urea cycle (21–23).
In this study, we utilized genetic and nuclear magnetic resonance (NMR) metabo-
lomics approaches to investigate amino acid catabolism in S. aureus USA300 JE2. We
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found that glutamate catabolism via GudB, which functions to replenish the tricarbox-
ylic acid (TCA) cycle via 2-oxoglutarate, is required for growth in a glucose-free medium.
In addition, ATP generated from the Pta/AckA pathway is also required for growth,
presumably due to a significantly reduced respiration rate. These data provide a model
suggesting that certain amino acid catabolic pathways are essential for growth in
niches where glucose is limiting.
RESULTS
Growth of S. aureus in complete defined medium containing 18 amino acids
but lacking glucose (CDM). Staphylococcal growth and central metabolism in tryptic
soy broth (TSB), which contains 14 mM glucose and an ill-defined concentration of
peptides and free amino acids, have been well studied (24). Therefore, to fully assess
amino acid catabolism, a complete defined medium was prepared as described by
Hussain and colleagues (25) except that no glucose was added. This medium contains
18 amino acids but excludes glutamine and asparagine. Aerobic growth of JE2 in CDM
reached a maximum optical density at 600 nm (OD600) of 3.0 following 8 h (Fig. 1A).
Acetate was produced at a concentration of 2.3 mM by 6 h of growth (Fig. 1A),
indicating catabolism of the glucogenic amino acids yielding pyruvate and the gener-
ation of acetate via Pta/AckA (26, 27). Acetate was subsequently consumed from the
medium as a secondary carbon source and presumably oxidized via the TCA cycle
(Fig. 1A) (28). Amino acid analysis of the spent medium demonstrated that alanine,
serine, glycine, threonine, arginine, proline, glutamate, and aspartate were rapidly
FIG 1 Growth of S. aureus JE2 in CDM. (A) Aerobic growth of JE2 in CDM displaying acetate and ammonia production. (B) Growth of JE2
and JE2 mqo1::N strains in CDM lacking aspartate (CDM-D). (C) Growth of JE2 putA::N, JE2 rocF::N, JE2 rocA::N, and JE2 hutU::N
strains in CDM lacking glutamate (CDM-E) in comparison to wild-type JE2. (D) Growth of JE2 rocF::N, JE2 ccpA::tetL, and JE2 wild-type
strains in CDM lacking proline (CDM-P) or arginine (CDM-R). Growth curve analyses whose results are shown in panels B to D were
performed in three independent experiments; error bars represent the standard errors of the means (SEM). Data in panel A are
representative of experiments performed three independent times.
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consumed by 8 h of growth, whereas histidine was not consumed until 12 h of growth
(Fig. 2). Consistent with these data was the generation of ammonia, which reached a
maximum concentration of 4.3 mM at 6 h of growth (Fig. 1A) and is indicative of amino
acid catabolism (29). There was a gradual consumption of other amino acids (cysteine,
lysine, phenylalanine, tyrosine, leucine, isoleucine, valine, and methionine) indicating
probable use for protein synthesis but not for catabolic purposes (Fig. 2).
Based on bioinformatics analyses and comparison with known pathways in Bacillus
subtilis and Escherichia coli, S. aureus JE2 encodes genes for enzymes that function to
catabolize amino acids to the metabolic intermediates pyruvate (from alanine, serine,
glycine, threonine, and cysteine), 2-oxoglutarate (from glutamate, glutamine, histidine,
arginine, and proline), and oxaloacetate (from aspartate and asparagine) (see Ta-
ble S1 in the supplemental material). Complete catabolic pathways could not be
identified for tryptophan, isoleucine, leucine, lysine, methionine, phenylalanine, ty-
rosine, and valine. Other than cysteine, which was not catabolized by JE2 in CDM
(Fig. 2), the results of these analyses agreed with our experimental observations as
detailed in Fig. 2. To determine which catabolic pathways are required for growth in
CDM, mutants from each predicted pathway (see Table S1) (ald and ald2, alanine;
sdaAA, serine, glycine, and threonine; aspA, aspartate; ansa, asparagine; rocF, arginine;
putA, proline; gudB, glutamate; hutU, histidine) were chosen from a sequence-defined
transposon library (30) and growth analysis was performed (Fig. 3 and S1A to I in the
supplemental material). These data demonstrated that only gudB (see Fig. S1H), which
encodes glutamate dehydrogenase and catalyzes the reaction between glutamate and
2-oxoglutarate, was required for growth in CDM. In addition, a transposon insertion
within putA (see Fig. S1G) resulted in a growth yield defect and mutations in ald (see
Fig. S1A) and aspA (see Fig. S1D) resulted in growth lag defects, although their growth
rates and yields were unaffected. Note that no phenotype was detected for ald2, which
FIG 2 Amino acid consumption of JE2 following growth in CDM. JE2 was grown aerobically in CDM, and amino acid concentrations (millimoles)
were measured in the supernatant at 0, 4, 8, and 12 h of growth. The results are representative of two independent experiments.
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codes for a second proposed alanine dehydrogenase (see Fig. S1B). Collectively, these
data suggest that amino acids which serve to fuel pyruvate (alanine) and oxaloacetate
(aspartate) synthesis are important for initiation of growth in CDM. In addition, carbon
derived from glutamate and those amino acids that can be converted to glutamate,
particularly proline, serves as the major carbon source for fueling the TCA cycle and
subsequent gluconeogenic reactions via phosphoenolpyruvate (PEP) carboxykinase
(coded for by pckA) (Fig. 3). On the basis of these observations, we predicted that
mutations in the TCA cycle enzymes generating oxaloacetate from 2-oxoglutarate
would also be required for growth. Therefore, transposon mutants in sucA (encoding
2-oxoglutarate dehydrogenase), sucC (succinyl coenzyme A [CoA] synthetase), sdhA
(succinate dehydrogenase), fumC (fumarase), and mqo1 (malate dehydrogenase) were
grown in CDM (see Fig. S1J to N). As predicted, no growth was observed with the sucA,
sucC, sdhA, and fumC mutants (Fig. 3; also see Fig. S1J to M). However, growth, albeit
delayed, was observed with the mqo1 mutant (Fig. 3; also see Fig. S1N). This suggests
that oxaloacetate can also be supplied by aspartate/glutamate transamination via
AspA. Indeed, an mqo1 mutant was unable to grow in CDM lacking aspartate (CDM-D;
Fig. 1B). However, since oxaloacetate supplied by aspartate cannot serve to comple-
ment the sucA, sucC, sdhA, or fumC mutants, these data suggest that these reactions
may have critical functions other than carbon catabolism. Lastly, as predicted, no
growth was observed for the pckA mutant, which is a critical enzyme required for
gluconeogenesis via the generation of phosphoenolpyruvate from oxaloacetate (Fig. 3;
also see Fig. S1O).
The putA (proline), rocF (arginine), hutU (histidine), and rocA (arginine and proline)
transposon mutants were grown in CDM lacking glutamate (CDM-E) to determine
which of the amino acid substrates that fuel glutamate synthesis are most crucial
(Fig. 1C). As a result, we found that the putA and rocA mutants had significant growth
yield defects whereas mutations in rocF and hutU resulted in only moderate growth
defects compared to wild-type JE2 grown in CDM-E. Thus, these data show that proline,
arginine, and histidine all serve to fuel glutamate synthesis when glutamate is limiting;
however, proline (obtained via PutA and RocA) is the major source of glutamate.
FIG 3 Amino acid catabolic pathways in S. aureus. Green arrows indicate those mutations that resulted in no significant growth defect
compared to wild-type JE2 in CDM. Blue arrows indicate those mutations that resulted in intermediate growth defects compared to
wild-type JE2 in CDM. Red arrows indicate mutations that completely inhibited growth of JE2 in CDM. Black arrows indicate that these
pathways were not tested. Please see Fig. S1 for growth analyses.
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As shown in Fig. 1A, growth of JE2 in CDM produces acetate, suggesting that the
glucogenic amino acids generating pyruvate (serine, threonine, glycine, and alanine)
are important for ATP synthesis via substrate-level phosphorylation in the Pta/AckA
pathway (27). To determine the importance of this pathway, a JE2 ΔackA mutant (27)
was grown in CDM and, as shown in Fig. S1P and Fig. 3, growth was significantly
reduced, suggesting that generation of ATP via this pathway may be critical to growth
using amino acids as carbon sources. Lastly, we found only a minor growth defect with
the pyc mutant, suggesting that pyruvate flux is directed primarily toward acetate
synthesis instead of oxaloacetate and the TCA cycle (Fig. S1Q and Fig. 3).
NMR metabolomic analysis of amino acid catabolism in S. aureus. The results of
the previously described experiments suggested that proline primarily serves to fuel
glutamate synthesis and thus may serve as the major carbon source to fuel gluconeo-
genesis when glutamate is limiting. In addition, it is predicted that the glucogenic
amino acids serine, threonine, glycine, and alanine are primarily catabolized to acetate
to fuel ATP synthesis. To address these hypotheses and to determine the fate of carbon
following amino acid catabolism, 13C-labeled glutamate, arginine, proline, aspartate,
histidine, serine, threonine, alanine, and glycine were individually added to CDM and
assayed via NMR metabolomics in mid- and post-exponential growth.
Glutamate, proline, and arginine. Metabolic intermediates originating from 13C-
labeled glutamate, proline, and arginine were very similar and included gluconeogenic
intermediates (glucose-6P and phosphoglycerate) and intermediates that function in
nucleotide biosynthesis (dihydroorotate, ribose, uracil, and adenosyl homocysteine)
and glycolipid/lipoteichioic acid synthesis (glucose 1-phosphate) (Fig. 4 and S2A to C)
(31). In addition, both aspartate and asparagine were detected from all three 13C-
labeled amino acids, suggesting that these amino acids were synthesized from oxalo-
acetate and the TCA cycle. Note that glutamate was synthesized from both proline and
arginine, presumably via RocA (Fig. 3 and 4 and S2A to C). However, as previously
reported, proline and arginine were not produced from glutamate (22). Importantly,
these results suggest that proline and arginine function as carbon sources as they both
serve as precursors for glutamate, the key intermediate linking carbon and nitrogen
metabolism. However, the amount of glutamate generated from proline was approx-
imately 5-fold greater than the amount generated from arginine (Fig. 4 and S2B and C).
And, as previously noted, a mutation in rocF had minimal effect on growth in CDM and
CDM-E. Note that JE2 contains two copies of arginine deiminase, which can generate
citrulline and ornithine from arginine while bypassing RocF (29, 32). However, an arcA1
arcA2 arginine deiminase mutant or a rocF arcA1 arcA2 mutant had no significant
growth defect in CDM (Fig. S1R and S1S). Thus, these NMR data are consistent with our
genotypic growth analysis and show that proline is rapidly catabolized to generate
glutamate to facilitate subsequent gluconeogenic reactions.
Previous work demonstrated that arginine is synthesized via proline and the urea
cycle in a ccpA mutant (22) but not through the well-defined glutamate-to-arginine
pathway as described for B. subtilis and other bacteria (33). Although genes for the arg
pathway are present in S. aureus, the growth conditions under which they are induced
are not known. In a similar manner, work from others (21, 23) demonstrated that
arginine served as a precursor for proline biosynthesis in a ccpA mutant via RocF, RocD,
and ProC. Electrophoretic mobility shift assay (EMSA) analysis demonstrated that CcpA
bound to the promoters of both rocF and rocD but not of proC (21). Thus, when
S. aureus is growing on nonpreferred carbon sources, an intact urea cycle is critical for
the interconversion of arginine and proline. Since CDM does not contain a preferred
carbon source, it is predicted that CcpA repression would be alleviated and that
pathways to interconvert proline and arginine would be transcriptionally active. As
predicted, proline synthesis was detected when 13C-labeled arginine was added to
CDM (Fig. 4B); however, arginine synthesis was not detected from 13C-labeled proline.
Instead, ornithine was detected from 13C-labeled proline, suggesting that, in addition
to its use in glutamate synthesis, carbon from proline also enters the urea cycle. To
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further investigate arginine synthesis in CDM, JE2 and JE2 ccpA::tet strains were grown
in media lacking either proline (CDM-P) or arginine (CDM-R). It was found that the JE2
ccpA::tetL strain grew in both CDM-P and CDM-R, although growth was delayed in
CDM-R (Fig. 1D). In addition, as predicted, the JE2 wild type grew in CDM-P but a rocF
mutant could not, suggesting that proline synthesis is fueled by arginine in CDM
(Fig. 1D). However, unexpectedly, but consistent with the NMR data, JE2 could not grow
in CDM-R, suggesting that proline cannot serve as a precursor for arginine synthesis in
the absence of a ccpA mutation.
Histidine and aspartate. Carbon derived from 13C histidine was primarily identified
in glutamate metabolism and cysteine biosynthesis intermediates (Fig. 4 and S2D).
Consistent with our amino acid analysis, where histidine was catabolized more slowly
than glutamate, proline, and arginine (Fig. 2), significantly more metabolites (especially
FIG 4 Summary of cellular metabolite concentration changes resulting from supplementation of uniformly labeled
amino acids in CDM. The bubble plot summarizes the metabolites derived from (U-13C4) aspartate (D), (U-13C5)
glutamate (E), (U-13C5) proline (P), (U-13C6) histidine (H), (U-13C6) arginine (R), (U-13C4) threonine (T), (U-13C3) serine
(S), (U-13C3) alanine (A), or (U-13C2) glycine (G) based on an analysis of triplicate 2D 1H-13C HSQC experiments. Due
to the wide dynamic range of NMR intensities, the original NMR peak intensities were transformed by natural
logarithm for the purpose of visualization. The relative sizes of the bubbles indicate the transformed values, where
a larger diameter indicates a higher NMR peak intensity. The bubbles are colored using a red gradient to represent
the original NMR peak intensity, where an increase in color intensity represents a corresponding increase in the
original NMR peak intensity. Each level of increase in red intensity corresponds to a 10-fold increase in the NMR
intensity. The bubbles with a purple outline identify metabolites observed during exponential phase. Bubbles with
a green outline identify metabolites observed during stationary phase. Metabolite names are colored based on the
assigned category as follows: orange, urea cycle; green, amino acid; black, glycolysis/gluconeogenesis; red, pentose
phosphate pathway/nucleosides; blue, others.
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glutamate) were identified in the post-exponential phase than in the exponential
phase. This observation suggests that histidine is catabolized after proline and arginine
are limited or depleted. As the carbon backbone of aspartate enters central metabolism
via oxaloacetate, it is not surprising that many metabolic intermediates derived from
13C aspartate were identified, including those that function in gluconeogenesis, the
pentose phosphate pathway, nucleotide biosynthesis, amino acid biosynthesis, and
glutamate metabolism (see Fig. S2E). Indeed, as noted in Fig. S1D, an aspA mutant
which was unable to synthesize oxaloacetate from aspartate had an increased lag
phase compared to the wild type.
Alanine, glycine, threonine, and serine. The metabolic intermediates derived from
these 13C glucogenic amino acids were very similar, reflecting their direct catabolism to
pyruvate (Fig. 4 and S2F to I). Similarly to other amino acids assayed, carbon derived
from the glucogenic amino acids was identified in gluconeogenic intermediates, other
amino acids, nucleotide biosynthesis, and glutamate. However, significantly more
extracellular acetate was derived from alanine, threonine, and serine than from other
amino acids (Fig. 5A). Therefore, we hypothesized that a bifurcation exists during amino
acid catabolism in which pyruvate generated from the glucogenic amino acids is
primarily utilized to generate acetate and ATP via AckA and little carbon enters the TCA
cycle via citrate synthase until acetate is consumed from the medium at 6 h of growth.
In addition, those amino acids that generate glutamate enter the TCA cycle at
2-oxoglutarate via GudB and serve as a carbon source to subsequently facilitate
gluconeogenesis (Fig. 3). Although it is clear from the NMR data that the 13C-labeled
glucogenic amino acids synthesize glutamate, this hypothesis predicts that mutations
within gltA (coding for citrate synthase), acnA (aconitase), and icd (isocitrate dehydro-
genase) would not abrogate growth in contrast to mutations in other TCA cycle genes
past the 2-oxoglutarate node. Indeed, transposon mutants with mutations within gltA,
acnA, and icd were grown in CDM, and, in contrast to the sucA, sdhA, and fumC TCA
cycle mutants, growth was observed, albeit with increased lag phase and growth rate
and yield defects (Fig. 3 and S1T to V). In agreement with this premise, intracellular
citrate concentrations, as an indicator of TCA cycle activity and entry of carbon into the
TCA cycle, increased 3-fold during post-exponential growth in CDM compared to
exponential growth (Fig. 5B). Collectively, since we detected citrate in early exponential
growth in CDM and we observed growth defects with the gltA, icd, and acnA mutants
even before acetate was depleted from the medium (6 h of growth; Fig. 1A), these data
suggest that the TCA cycle is active throughout growth in CDM but that carbon flux is
reduced through the TCA cycle and is instead routed to acetate when amino acids that
generate pyruvate are present in the medium. Once these amino acids (primarily serine,
threonine, and alanine) are depleted, acetate is consumed and enters the TCA cycle to
generate 2-oxoglutarate.
Respiration is reduced, but is required for viability, during growth of S. aureus
in CDM. As an ackA mutant was unable to grow in CDM, we hypothesized that the ATP
generated by acetate kinase is critical for growth under these conditions. We reasoned
that the reducing power generated by the TCA cycle is utilized during gluconeogenesis
to regenerate NAD and maintain redox balance. Thus, the net level of NADH may be
reduced during growth in CDM below the levels needed to drive oxidative phosphor-
ylation from the staphylococcal NADH:quinone oxidoreductase. Therefore, experiments
were designed to determine if respiration is reduced during growth in CDM compared
to TSB or CDM containing 14 mM glucose (CDMG). The relative rate of oxygen
consumption during growth in CDM was approximately 50% of the rate in TSB, and the
rate was significantly lower than that detected in CDMG (Fig. 5C). Consistent with these
observations, the relative intracellular ATP concentration during growth in CDM was
12% of the concentration in TSB (Fig. 5D). Collectively, these data suggest that growth
in CDM yields significantly decreased respiratory activity and coincident ATP synthesis.
S. aureus contains a branched respiratory chain and has two terminal menaquinol
oxidases, QoxABCD (34, 35) and CydAB (36). QoxABCD is promiscuous and can function
Halsey et al. ®
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as both a cytochrome aa3-type and bo3-type oxidase, whereas CydAB is a bd-type
oxidase (37). Respiratory complexes that feed the menaquinone pool include succinate
dehydrogenase (Sdh) (38), Lqo (4, 6, 39), and malate quinone oxidoreductase (Mqo) (4,
6). Furthermore, S. aureus does not contain a complex I NADH oxidoreductase but
instead encodes a type 2 nonelectrogenic NADH:quinone oxidoreductase (Ndh2) that
may be linked to MpsA, a NuoL-like protein that functions to translocate cations but has
no NADH binding capability (40). The lack of growth demonstrated by a succinate
dehydrogenase mutant (Fig. 3 and S1L) and the decreased ATP concentration and
oxygen consumption noted during growth in CDM led us to address the importance of
the electron transport chain during growth in CDM. Transposon mutants deficient in
NADH:quinone oxidoreductase (coded for by nrd; SAUSA300_0844) and quinol oxidase
(qox) were grown in CDM; both the nrd mutant and the qox mutant were unable to
grow aerobically in CDM (Fig. 6A). Furthermore, growth of S. aureus was halted in CDM
when the ATP synthase inhibitor DCCD (N,N=-dicyclohexylcarbodiimide) was added to
the medium in early exponential phase (Fig. 6B). In contrast, DCCD had little effect on
FIG 5 Metabolic indicators of JE2 growth in CDM, TSB, or CDMG. (A) Extracellular acetate detected following aerobic growth in CDM containing (U-13C4)
aspartate (D), (U-13C5) glutamate (E), (U-13C5) proline (P), (U-13C6) histidine (H), (U-13C6) arginine (R), (U-13C4) threonine (T), (U-13C3) serine (S), (U-13C3) alanine (A),
or (U-13C2) glycine (G). NMR peak intensity was assessed in early exponential (early), mid-exponential (middle), and late exponential (late) growth based on an
analysis of the results of triplicate 2D 1H-13C HSQC experiments. Error bars represent standard errors of the means. (B) Intracellular concentration of citrate as
measured in early and post-exponential phases of growth in CDM. (C and D) Relative rate of oxygen consumption (C) and ATP concentration (D) following
growth of JE2 in CDM, CDMG, or TSB. Rates of JE2 grown in TSB were set at 100%. Samples for panels C and D were collected in mid-exponential phase. For
panels B to D, significance was determined via an unpaired Students t test with Welch’s correction (*, P  0.05; ***, P  0.001; ****, P  0.0001).
Amino acid catabolism in Staphylococcus aureus ®
January/February 2017 Volume 8 Issue 1 e01434-16 mbio.asm.org 9
growth in TSB or CDMG (see Fig. S3A and B). Collectively, the results of these experi-
ments suggest that ATP generated via both substrate-level phosphorylation and oxi-
dative phosphorylation is required for growth in CDM and that the importance of the
PTA-AckA pathway under these conditions is most likely linked to the reduced rate of
respiration. Note that a cydA mutant had no growth phenotype, suggesting that the
cytochrome bd oxidase does not have a recognizable function during growth in CDM
(see Fig. S1W).
Growth of gudB and ackA mutants in CDM is impaired under conditions of
anaerobic growth. The infection model proposed by Spahich and colleagues suggests
that S. aureus growth under conditions of mild NO stress within an anoxic, glucose-
depleted abscess requires both lactate and peptides. Thus, we assessed whether gudB
and ackA were also required for growth in CDM under anaerobic growth conditions. JE2
was grown in CDM with or without lactate and/or nitrate, which was used as a terminal
electron acceptor. These experiments demonstrated that enhanced growth was ob-
served only in CDM containing lactate and nitrate as previously described (4, 6)
(Fig. 6C). Thus, JE2 gudB::N and JE2 ackA strains were grown in CDM containing lactate
and nitrate. As predicted, no growth was observed for either of these mutants (Fig. 6D).
S. aureus does not utilize proline or arginine during growth in CDMG. During
our initial studies of growth in CDM, we noted several differences when 14 mM glucose
was added to the medium. First, aerobic growth of S. aureus JE2 in CDMG reached an
OD600 maximum of approximately 5.5 following 6 h of growth, at which time glucose
was exhausted from the medium (see Fig. S4A). In contrast to the results seen with
growth in TSB (28) and CDM (Fig. 1A), acetate was not completely consumed from
CDMG, suggesting that growth arrest and subsequent acetate oxidation via the TCA
FIG 6 Importance of aerobic and anaerobic respiration during growth in CDM. (A) Aerobic growth of JE2, JE2
qoxB::N, and JE2 nrd2::N strains in CDM. (B) Growth of JE2 in CDM following the addition of the ATP synthase
inhibitor DCCD in early exponential phase. (C) Anaerobic growth (24 h) of JE2 in CDM containing either 3 mM
sodium nitrate or 0.5% lactate (CDML). (D) Anaerobic growth (24 h) of JE2, JE2 gudB::N, and JE2 ackA strains grown
in CDM containing sodium nitrate (3 mM) and lactate (0.5%). Growth curve analyses were performed in three
independent experiments; error bars represent the standard errors of the means (SEM).
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cycle may be halted due to depletion of critical amino acids or other C4/C5 compounds
as previously discussed (38), although the exact mechanisms are not clear (see
Fig. S4A). Amino acid analysis of spent medium demonstrated that aspartate, gluta-
mate, lysine, and the glucogenic amino acids alanine, serine, glycine, and threonine
were rapidly depleted from the medium (Fig. 7). However, the remaining amino acids,
including arginine, histidine, and proline, that are known to generate glutamate during
growth in CDM were incompletely utilized following 12 h of growth. In fact, a mutation
in gudB had little effect on growth in CDMG, in contrast to that observed with growth
in CDM (see Fig. S4B). As discussed previously, investigations have shown that arginine
and proline catabolism is repressed via CcpA and carbon catabolite repression (21, 22).
However, following glucose consumption at 6 h of growth, rapid arginine and/or
proline catabolism was not observed. Furthermore, no growth was observed in CDMG
when proline (CDMG-P) or arginine (CDMG-R) was subtracted from the medium (see
Fig. S4C). In contrast, a lack of glutamate in CDMG (CDMG-E) did not result in a
significant growth defect (see Fig. S4C). NMR analysis performed using 13C6-labeled
glucose confirmed that glucose was metabolized to synthesize glutamate, thus facili-
tating growth in CDMG-E (see Fig. S5). However, almost undetectable levels of 13C-
labeled arginine or proline were detected during growth with CDMG containing
13C6-labeled glucose, confirming previous data demonstrating that arginine and pro-
line need to be acquired from exogenous sources when S. aureus grows on preferred
carbon sources such as glucose (21, 22). Collectively, these data suggest that growth of
FIG 7 Amino acid consumption of JE2 following growth in CDMG. JE2 was grown aerobically in CDMG, and amino acid concentrations
(mM) were measured from the supernatant at 0, 4, 8, and 12 h of growth. The results are representative of two independent
experiments.
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S. aureus in CDMG results in rapid utilization of glucose, serine, threonine, alanine,
glycine, glutamate, lysine, and aspartate. However, proline and arginine, key amino
acids that fuel glutamate synthesis under conditions of growth in CDM, are not utilized
as a carbon source when glucose is exhausted from CDMG. Both proline and arginine
are required for growth in CDMG for utilization during protein synthesis, however, as
glutamate does not serve as a substrate for their synthesis. Lastly, it is unclear how
lysine is rapidly utilized during growth in CDMG, as pathways that function to catab-
olize lysine were not identified in S. aureus FPR3757 (see Table S1).
putA, rocD, hutU, rocA, gudB, and rocF are regulated via carbon catabolite
repression and CcpA. The results of the studies described above suggest that proline
and arginine catabolism is dependent upon carbon catabolite repression. Indeed,
previous studies demonstrated that the interconversion of proline and arginine is
repressed via CcpA at rocF, rocD, and putA in the presence of glucose (21, 22), indicating
that these amino acids (which can be converted to glutamate) can be used as
alternative carbon sources. Therefore, it was hypothesized that the conversion of
histidine to glutamate, in addition to the conversion of arginine and proline to
glutamate via pyrolline-5 carboxylate and RocA and the subsequent conversion of
glutamate to 2-oxoglutarate via GudB, would also be CcpA repressed, as these reactions
would be necessary only if there were no other preferred carbon sources available
(Fig. 3). Therefore, Northern blots were utilized to assess transcription of putA, rocD,
hutU, rocA, gudB, and rocF in both JE2 and a JE2 ccpA::tetL mutant following growth in
CDMG and CDM. These experiments revealed that transcription of putA, rocD, rocA,
gudB, and rocF was induced after glucose was exhausted from CDMG (Fig. 8). In
addition, as expected, transcription of putA, rocD, rocA, gudB, and rocF in exponential
FIG 8 Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and hutU following growth in CDM and
CDMG. Northern analysis was performed with RNA isolated from exponential (early) and post-
exponential (late) phases of growth (both CDM and CDMG) from JE2 and JE2 ccpA::tetL strains. Equal
loading of RNA was ensured via staining of the RNA gel with ethidium bromide and visualization of the
16S and 23S rRNA (data not shown).
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growth was ccpA dependent, as transcription was detected in the JE2 ccpA::tetL mutant
following exponential growth in CDMG. Furthermore, as predicted, transcription of
putA, rocD, rocA, gudB, and rocF was detected during exponential growth in CDM.
Transcription of hutU, in contrast, was detected only in the JE2 ccpA::tetL mutant in the
exponential phase of growth and not in the exponential phase of growth of wild-type
JE2. On the basis of the NMR and amino acid utilization data (Fig. 2 and 4), we predicted
that hutU transcript would be detected in the post-exponential-growth phase following
proline and arginine depletion in CDM, but we were unable to detect this transcript
during our initial studies. In addition, hutU transcript was not detected in CDMG, even
in the ccpA mutant. These data may suggest that growth arrest occurs in CDMG before
potentially multiple regulatory networks induce hutU expression. Indeed, histidine
catabolism in B. subtilis is regulated via both CcpA and CodY (41, 42). Therefore, to
further assess hutU transcription, RNA was collected during growth in CDM from 8 to
12 h. Note that hutU transcript was detected at both 11 and 12 h of growth (Fig. 8),
which is consistent with the NMR (Fig. 4 and S2D) and amino acid utilization (Fig. 2)
data demonstrating that histidine is catabolized only when proline and arginine are
limited. Collectively, these data demonstrate that pathways that function to fuel
glutamate catabolism, and gudB, which fuels the TCA cycle from glutamate, are all
regulated by CcpA and are induced only when glucose is not present in the medium.
DISCUSSION
Our knowledge of how S. aureus proliferates within multiple niches of the host is limited.
Nevertheless, recent studies have found that S. aureus can adapt to changing levels of
carbon sources and oxygen availability found within specific organ systems. For example,
Hammer and colleagues determined that S. aureus bacteria defective in aerobic respiration
were unable to mediate infection in the heart or liver but that colonization and abscess
formation in the kidney were unaffected (35). Complementing these findings, S. aureus
mutants defective in anaerobic fermentation were less virulent than the wild type in a
mouse model of kidney infection (5). Additionally, mutants defective in CcpA were less
effective at infecting the liver where glucose was abundant, but the infection burden in the
kidney was not affected (21). Thus, taken together, these data suggest that S. aureus uses
distinct central metabolic pathways to adapt to the different carbon or oxygen sources that
are available within the organ system or site of infection.
An elegant model has emerged demonstrating how S. aureus survives within a
staphylococcal abscess (6). The antimicrobial action of NO occurs at multiple nodes of
central metabolism, including the TCA cycle and respiration. However, the NO concen-
tration at the center of staphylococcal abscesses is thought to be below 1 M, allowing
respiration and other metabolic processes to be functional (15, 43). Furthermore,
glucose is depleted due to phagocytic cell activity, whereas lactate is abundant due to
excretion during staphylococcal growth (6, 16). Thus, the major carbon sources for
S. aureus at the center of abscesses are lactate and peptides. Lactate is utilized via
lactate quinone oxidoreductase (Lqo), which generates pyruvate and subsequently
acetate via Pta/AckA, whereas peptides provide a carbon source for gluconeogenesis.
The goal of the study was to assess amino acid catabolism and to determine the
importance of particular amino acid catabolic pathways during growth without glucose
or other preferred carbon sources.
Bioinformatic analyses of USA300 LAC (32) found that S. aureus has the potential
ability to catabolize 11 amino acids to pyruvate, oxaloacetate, or 2-oxoglutarate (see
Table S1 in the supplemental material). It should be noted that these pathways are
predicted and that novel pathways could be present in S. aureus. However, growth in
CDM and subsequent amino acid analysis verified the predictions for 10 of the
11 amino acids. Our results are similar to those of previously published studies
assessing amino acid catabolism or utilization in S. aureus, although the media used
varied slightly in these studies (44–46). The lone amino acid not catabolized, but
predicted based on bioinformatics analyses, was cysteine. This result may have oc-
curred because CDM contains MgSO4 as a sulfur source. It is well established that
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S. aureus cannot utilize sulfate, sulfite, or sulfonates as the source of sulfur in cysteine
biosynthesis, whereas it can use thiosulfate, sulfide, or glutathione (47). Thus, we
predict that a feedback mechanism exists for repressing cysteine catabolism if an
appropriate sulfur source for cysteine synthesis is not present. In addition, we observed
that lysine was catabolized when S. aureus was grown in CDMG but not CDM. Some
species are known to ferment lysine to acetate (48), but metabolic pathways to perform
this function are not immediately recognized in the S. aureus genome.
Glutamate is the major amino donor for most anabolic enzymatic reactions and yet
also functions as a key intermediate in carbon metabolism (49, 50). Our results suggest
that glutamate, and those amino acids that can be converted into glutamate, serves as
a central carbon source to facilitate growth in media lacking a preferred carbon source
such as glucose. First, glutamate dehydrogenase (GudB), an enzyme that catalyzes the
conversion of glutamate to 2-oxoglutarate, is required for growth in CDM. In addition,
all enzymes (excluding Mqo1, which is rescued by anaplerotic reactions generating
oxaloacetate) that function in the TCA cycle downstream of 2-oxoglutarate, including
phosphoenolpyruvate carboxykinase (PckA), which generates PEP from oxaloacetate,
are required. Thus, glutamate fuels the TCA cycle allowing subsequent gluconeogenic
reactions and presumably serves as the major amino group donor to cellular reactions.
Second, although NMR analysis found that 13C carbon from all of the amino acids
tested eventually was incorporated into glutamate, only mutations in those genes that
code for enzymes that function to generate glutamate from proline resulted in a
significant growth defect. Other than arginine, histidine, and proline, all amino acids
must generate glutamate via the TCA cycle and glutamate synthase (GOGAT). However,
a mutation in gltB (encoding a large subunit of glutamine oxoglutarate aminotransfer-
ase [GOGAT]; see Fig. S1X in the supplemental material) conferred no growth defect in
CDM, suggesting that the importance of glutamate synthesis from amino acids other
than proline and histidine is minimal. As indicated by NMR, arginine can also be directly
converted to glutamate by the arginase pathway (RocF-RocD-RocA) (Fig. 3). Alterna-
tively, independently of RocF, arginine deiminase (29) can synthesize ornithine from
arginine, which can then be catabolized to glutamate via RocD and RocA. However,
individual rocF (see Fig. S1F) and arcA1 arcA2 (see Fig. S1R) mutants did not have a
growth defect in CDM, whereas a rocF arcA1 arcA2 (see Fig. S1S) mutant had only a
post-exponential growth defect, suggesting that arginine catabolism does not signifi-
cantly contribute to exponential growth. However, it was surprising that a rocD mutant
had a growth phenotype in CDM similar to that of the rocA mutant (see Fig. S1Y and
Z); RocD converts ornithine, which can be synthesized from arginine via RocF, to P5C
(1-pyrroline-5-carboxylic acid) (Fig. 3). Since the rocF (see Fig. S1F) mutant did not have
a significant growth defect, one would predict that a rocD mutant would phenocopy a
rocF mutant. S. aureus also encodes a nitric oxide synthase (nos), which catalyzes the
formation of citrulline from arginine, generating NO (51). Thus, it is possible that
arginine is primarily catabolized via NOS and not arginase or arginine deiminase during
growth in CDM, but whether this is the case is currently unknown. Nevertheless,
complementing these genetic findings, comparison of NMR peak intensities suggested
that the level of glutamate synthesized via proline was approximately 5 times and 6
times that synthesized from arginine in the exponential and post-exponential phases,
respectively, and was approximately 5 times and 2.5 times that synthesized from
histidine in the exponential and post-exponential phases, respectively (Fig. 4). Thus, as
our NMR and amino acid utilization data demonstrate, histidine is utilized after proline
levels become limiting. Collectively, our data suggest that proline is the primary
substrate for glutamate synthesis during exponential phase and that histidine is utilized
once proline is limiting. Furthermore, arginine is a minor source of glutamate synthesis
in both the exponential and post-exponential phases of growth.
Lastly, we found that the entire metabolic pathway that functions to catabolize both
proline and arginine is under carbon catabolite and CcpA control. Thus, proline,
histidine, and arginine are catabolized only when glucose is limiting. However, why is
proline the primary source of glutamate when S. aureus is growing without glucose? We
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have previously proposed a model whereby arginine is rapidly depleted within an
abscess due to its preferential uptake by host innate immune cells for inducible nitric
oxide synthase (iNOS) (52), arginase (53, 54), and cell-mediated (55) immunity, effec-
tively reducing the amount of free extracellular arginine available in the microenviron-
ment. Previous studies have shown significant induction of both iNOS and arginase
expression during S. aureus abscess formation (22), further suggesting that arginine
depletion occurs at the infection site. Although nothing is known regarding the
concentration of free proline or histidine in a staphylococcal infection, proline is the
second-most-abundant amino acid found in collagen, which is the most abundant
protein in animals (56). Indeed, collagen is a major constituent of the fibrotic wall
surrounding a staphylococcal abscess (22). We hypothesize that S. aureus uses a
combination of host-derived proteases, known to be induced to facilitate tissue re-
modeling during abscess formation (57, 58), and its own proteases that are known to
degrade collagen (59–61) to liberate free proline or proline-containing peptides that
are subsequently utilized by S. aureus to synthesize arginine and glutamate. Thus, since
proline is likely to be present at high concentrations in abscesses and can be trans-
formed to both arginine and glutamate, it is proposed that S. aureus has evolved to
rapidly synthesize both glutamate and arginine from proline when preferred carbon
sources such as glucose are lacking.
We also propose that catabolism of the glucogenic amino acids (e.g., serine,
threonine, and alanine) during growth in CDM functions primarily to generate acetate
and ATP via substrate-level phosphorylation. Several observations suggested that
conversion of acetyl-CoA to 2-oxoglutarate is most active in the post-exponential phase
during growth in CDM. First, acetate consumption, as an indicator of TCA cycle activity,
is observed during the post-exponential phase (Fig. 1A). Second, citrate concentrations,
another indicator of TCA cycle activity, increase significantly in the post-exponential
phase during growth in CDM (Fig. 5A). Third, in contrast to the results seen with TCA
cycle enzymes that function to generate oxaloacetate from 2-oxoglutarate, mutations
in gltA, acnA, or icd do not abrogate growth. Thus, we propose that the glucogenic
amino acids are catabolized to acetate via Pta/AckA and secreted. The acetate is
subsequently catabolized via the TCA cycle in the post-exponential phase since acetate
represents a secondary carbon source. This supposition is supported by the findings
indicating that 13C-labeled glutamate was primarily detected in the post-exponential
phase when CDM was supplemented with 13C-labeled alanine, serine, or threonine.
Glutamate can be synthesized from these amino acids only via TCA cycle activity and
generation of glutamate via GOGAT and 2-oxoglutarate.
Why is a mutation in ackA deleterious to growth in CDM? Although a mutation in
ackA is detrimental to growth in TSB, it does not completely abrogate growth but
instead enhances glycolytic flux and diverts carbon to the TCA cycle (27). We first
hypothesized that the ATP generated via AckA was fundamentally important due to a
decrease in ATP generation via the respiratory chain during growth in CDM. However,
although we found that oxygen consumption, ATP synthesis, and the NAD/NADH
ratio are significantly decreased during growth in CDM compared to TSB, we found that
mutations in NADH dehydrogenase and quinol oxidase were also deleterious to
growth. In addition, time-kill curve experiments performed using the ATP synthase
inhibitor DCCD halted growth in CDM whereas growth was unaffected in TSB and
CDMG. Thus, we propose that the ATP generated from both AckA and ATP synthase via
respiratory activity is important for growth in CDM. Indeed, amino acid transport
requires ATP and is a more energy-intensive process than carbohydrate transport,
which is facilitated through the phosphotransferase (PTS) system. Supporting this
notion, anaerobic growth of JE2 in CDM required both lactate and nitrate and was gudB
and ackA dependent. These data suggest that glutamate catabolism, substrate-level
phosphorylation, and ATP derived from anaerobic respiration were all required for
growth in an anaerobic environment which mimicked the anoxic environment found in
an abscess (Fig. 6C). Alternatively, the lack of growth in CDM with an ackA mutant may
be linked to recycling of coenzyme A, which is required for the conversion of
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2-oxoglutarate and succinyl-CoA via SucA (62). However, it is unclear how a mutation
in ackA would affect activity of Pta, which functions to generate acetyl phosphate while
regenerating CoA. Additionally, recent studies have documented that an ackA mutant
generates a redox imbalance in S. aureus (26). Thus, the growth phenotype observed
with the ackA mutant may be multifactorial.
Finally, multiple pathways fueling glutamate catabolism (synthesis from proline,
arginine, and histidine) are all under the control of repression of CcpA and thus are
active only when preferred carbon sources such as glucose are depleted. This provides
a rapid mechanism to facilitate growth using amino acids as carbon sources when
glucose is not available. However, it is unclear why growth of JE2 in CDM-R is
dependent upon a mutation in ccpA. One would expect that CcpA repression would be
alleviated during growth in CDM without a preferred carbon source available. However,
we did not observe growth of JE2 in CDM-R, and growth of the JE2 ccpA::tetL mutant
in CDM-R was dependent upon putA, suggesting that proline was the source of
arginine, as previously described (22). This observation may suggest that regulation of
the urea cycle may involve multiple layers of regulation, including CcpA regulation. In
addition, GudB in B. subtilis is upregulated by the presence of proline, arginine, or
ornithine (63); thus, it is possible that gudB transcription requires arginine, at least in the
presence of CcpA, to be fully functional. However, it should be noted that slight growth
of JE2 in CDM-R was observed after 24 to 30 h of growth, but the significance of this
observation is not clear (data not shown).
In conclusion, we have found that glutamate, and those amino acids that serve to fuel
its synthesis, are central carbon sources during growth in medium lacking glucose. In
addition, the glucogenic amino acids are catabolized to generate acetate and produce ATP
via AckA; the ATP generated via this reaction is critical for growth in medium lacking
glucose such as CDM. Further work is required to determine the function and expression of
these catabolic pathways to determine their importance in vivo.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The S. aureus strains used in this study were all derived
from JE2 (30). Defined bursa aurealis transposon mutants were obtained from the Nebraska Transposon
Mutant Library and backcrossed to JE2 using 11 (30). The JE2 ccpA and JE2 ackA strains have been
previously described (22, 27, 64). S. aureus strains were grown in tryptic soy broth (TSB; Becton, Dickinson,
Franklin Lakes, NJ); complete defined medium (CDM), as previously described (25), except no glucose was
added; or CDM with 0.25% glucose (CDMG). Cultures were grown aerobically in a 10:1 flask-to-volume
ratio, with shaking at 250 rpm at 37°C. S. aureus cultures were inoculated to an optical density at 600 nm
(OD600) of 0.05 from washed (phosphate-buffered saline [PBS]) overnight cultures grown in TSB, CDM, or
CDMG. Bacterial growth was assessed by measuring the optical density at 600 nm. Anaerobic growth was
measured in an anaerobic chamber (Coy Laboratory Products, Inc., Grass Lakes, MI) using a 10:1
flask-to-volume ratio in CDM supplemented with 1.0 g/liter L-cysteine hydrochloride (Sigma) with or
without the addition of L-lactate (0.5%) and/or sodium nitrate (20 mM). Growth was assessed in the
anaerobic chamber with shaking at 37°C and 250 rpm to ensure that the cells did not settle in the flask.
For time-kill curve experiments using ATP synthase inhibitors, 100 M DCCD (N,N=-dicyclohexylcarbo-
diimide)–95% ethanol was added to cultures during early exponential growth (OD600  0.5 for CDM and
1.0 for TSB and CDMG). The putA (pNF275) and gudB (pNF311) complement plasmids were constructed
using pBK123 (65). putA was cloned into the PstI and BamHI restriction sites of pBK123 using primers
2344 and 2345 (see Table S2 in the supplemental material), whereas gudB was cloned into the
Pst1/BamHI restriction sites using primers 2846 and 2848 (see Table S2).
Measurement of bacterial metabolites. Bacterial cultures were collected (1-ml aliquots) and
centrifuged at 14,000 rpm for 3 min. The supernatants were removed and stored at 80°C until use.
Acetic acid, glucose, ammonia, and D- and L-lactic acid concentrations were determined according to the
instructions of the manufacturer using kits purchased from R-Biopharm.
Measurement of TCA cycle and respiration activity. For all assays, JE2 was grown overnight
aerobically in 25 ml of appropriate media. Cultures were inoculated to an OD600 of 0.05 in TSB, CDM, or
CDMG and were grown to early exponential phase (OD600  0.5 for CDM and 1.0 for TSB and CDMG).
ATP concentration. Intracellular ATP concentrations were determined using a BacTiter-Glo kit
(Promega) according to the manufacturer’s protocol and normalized to total optical units.
NAD/NADH concentration. Aliquots of bacterial cultures (24 ml) were harvested by centrifugation
at 4°C for 10 min at 4,000 rpm. Intracellular NAD and NADH concentrations were determined using a
fluorescent NAD/NADH kit (Cell Technology) as previously described (27) and normalized to total
cellular protein concentrations.
Oxygen consumption. Samples were collected and diluted in air-saturated TSB, CDM, or CDMG to
an OD600 of 0.3. Relative oxygen consumption rates were determined for up to 120 min at 37°C by using
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a MitoXpress oxygen-sensitive probe (Luxcel Biosciences) according to the manufacturer’s instructions
and normalized to total optical units.
Citrate concentrations. Aliquots of bacterial cultures (24 ml) were harvested by centrifugation at 4°C
for 10 min at 4,000 rpm. The bacterial pellets were washed twice with 1 ml of phosphate-buffered saline
(pH 7.4) (PBS) and subsequently resuspended in 0.5 ml PBS, followed by the addition of 0.1 ml ice-cold
3 M perchloric acid. The cells were lysed using lysing matrix B tubes in a FastPrep FP120 instrument
(Qbiogene, Inc.). The lysates were centrifuged for 3 min at 14,000 rpm. Subsequently, 300 l of
supernatant was neutralized with 75 l of saturated solution of potassium bicarbonate and centrifuged
at 4°C for 3 min at 14,000 rpm. Intracellular citrate concentrations in the lysates were determined by
using a citrate fluorometric assay kit (BioVision) according to the manufacturer’s protocol and normalized
to total cellular protein concentrations.
Amino acid analysis. JE2 was grown overnight in 50 ml (500-ml flask) of CDMG. Cultures were
inoculated to an OD600 of 0.05 in CDM or CDMG and grown for 12 h. One milliliter of media was collected
every 4 h and pelleted for 3 min at 14,000 rpm. Supernatant was collected and filtered through Amicon
Ultra centrifugal filters (Millipore) (3,000 molecular weight cutoff [MWCO]) according to the manufac-
turer’s protocol. Amino acid analysis was performed by the Protein Structure Core Facility, University of
Nebraska Medical Center (UNMC), using a Hitachi L-8800 amino acid analyzer.
NMR sample preparation. Three independent 50-ml cultures of S. aureus JE2 were grown to
exponential phase (OD600  0.8 to 1.0) and post-exponential/stationary phase (OD600  2.0 to 2.2) in
CDM containing 13C5-labeled glutamate, 13C5-labeled proline, 13C6-labeled arginine, 13C6-labeled glucose,
or 13C3-labeled pyruvate (Sigma-Aldrich). Cultures were normalized to an OD600 of 40 and pelleted by
centrifugation (6,000 rpm at 4°C for 5 min). Pellets were subsequently washed two times with 10 ml of
cold sterile water and resuspended in 1 ml cold sterile water and transferred to a lysing matrix B tube
(MP Biomedicals). The pellet was lysed using an FP120 FastPrep cell disrupter (MP Biomedicals) and
centrifuged at 13,200 rpm for 15 min at 4°C. The pellet was reextracted by the use of 1 ml cold sterile
water. Supernatants from the two extractions were combined and stored at 80°C for NMR analysis.
NMR data collection and analysis. The collected supernatants were lyophilized and reconstructed
in NMR buffer (KH2PO4/K2HPO4 buffer–D2O [pH 7.4] [uncorrected], with 500 M trimethylsilylpropanoic
acid [TMSP] as an internal standard). Two-dimensional (2D) 1H-13C heteronuclear single-quantum coher-
ence (HSQC) spectra were collected on a Bruker DRX Avance 500-MHz spectrometer equipped with a
5-mm-long triple-resonance cryoprobe (1H, 13C, and 15N) with a z axis gradient, a BACS-120 sample
changer, Bruker IconNMR, and an automatic tuning and matching (ATM) unit. NMRPipe (28) and
NMRViewJ (29) were used to process and analyze the collected spectra. The TMSP internal standard was
used for chemical shift referencing and normalization of NMR peak intensities. NMR peaks from the 2D
1H-13C HSQC spectra were annotated by comparing the observed 1H and 13C chemical shifts to the
metabolite reference data from the Platform for RIKEN metabolomics (PRIMe; http://prime.psc.riken.jp/)
(30), Human Metabolome Database (HMDB; http://www.hmdb.ca/) (31), Madison metabolomics Consor-
tium Database (http://mmcd.nmrfam.wisc.edu/) (32), Metabominer (http://wishart.biology.ualberta.ca/
metabominer/) (33), and BiomagResBank (BMRB; http://www.bmrb.wisc.edu//) (34) with error tolerances
of 0.08 ppm and 0.25 ppm for 1H and 13C chemical shifts, respectively. The relative intensity (i.e.,
concentration) of each metabolite was calculated by averaging the intensities of all NMR peaks unam-
biguously assigned to the metabolite.
RNA isolation and Northern blot analysis. Cultures of S. aureus JE2 and JE2 ccpA strains were
grown overnight in CDM and CDMG and inoculated to an OD600 of 0.05 into TSB (TSB overnight), CDM,
and CDMG, respectively. Cultures were grown at 37°C in a 1:10 vol-to-flask ratio at 250 rpm. Fifteen
milliliters of bacterial culture was collected at the mid-exponential phase (3 h to 6 h) and the post-
exponential phase (7 h to 10 h) of growth and pelleted at 5,000 rpm for 10 min at 4°C. Pellets were
resuspended in RLT buffer (Qiagen, Inc.) with 1% -mercaptoethanol and transferred to lysing matrix B
tubes (MP Biomedicals). They were then processed in an FP120 FastPrep cell disrupter (MP Biomedicals)
for 24 s at a setting of 6.0. Cells were then pelleted at 13,000 rpm for 15 min at 4°C. The top phase was
combined with 500 l of ethanol, and the samples were then processed using an RNeasy minikit,
according to the instructions of the manufacturer (Qiagen, Inc.) Primers listed in Table S2 were used to
make DNA probes, which were subsequently labeled with digoxigenin (DIG)-labeled dUTP (Roche). One
microgram of RNA was used for Northern analysis, which was performed using DIG buffers and washes
(Roche). Anti-digoxigenin-AP Fab fragments (Roche) was used with ECF substrate (GE Healthcare) for
detection. Blots were visualized using a Typhoon FLS 7000 imaging system (GE Healthcare).
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Table S1.  Predicted amino acid catabolism in Staphylococcus aureus FPR3757a 
 
Amino acids yielding pyruvate 
Amino acid  Reaction    Enzyme   FPR3757  
Alanine   (1) Alanine yielding pyruvate  Alanine Dehydrogenase  SAUSA300_1331 (ald) 
         (EC 1.4.1.1)  SAUSA300_1655 (ald2) 
 
Serine   (1) Serine yielding pyruvate  Serine Dehydratase  SAUSA300_2469 (sdaAA) 
         (EC 4.3.1.7)  SAUSA300_2470 (sdaAB) 
 
Glycine   (1) Glycine yielding Serine  Serine Hydroxymethyl  SAUSA300_2067 
      (via 5,10 methylenetetrahydrofolate   Transferase 
       and glycine cleavage enzyme)  (EC 2.1.2.1) 
     Glycine Dehydrogenase  SAUSA300_1496 
      (EC 1.4.4.2)  SAUSA300_1497 
     Glycine Cleavage System SAUSA300_0791 (gcvH) 
      H protein 
     Glycine Cleavage System  SAUSA300_1498 (gcvT) 
      T protein 
      (EC 2.1.2.10) 
     Dihydrolipoamide Dehydrog- SAUSA300_0996 (lpdA) 
      enase 
      (EC 1.8.1.4) 
(2) Serine yielding pyruvate  Serine Dehydratase  SAUSA300_2469 (sdaAA) 
         (EC 4.3.1.7)  SAUSA300_2470 (sdaAB) 
 
Threonine  (1) Threonine yielding Glycine  Threonine Aldolase  SAUSA300_1214 
         (EC 4.1.2.5) 
 
   (2) Glycine yielding Serine  Serine Hydroxymethyl  SAUSA300_2067 
      (via 5,10 methylenetetrahydrofolate   Transferase 
       and glycine cleavage enzyme)  (EC 2.1.2.1) 
     Glycine Dehydrogenase  SAUSA300_1496 
      (EC 1.4.4.2)  SAUSA300_1497 
     Glycine Cleavage System SAUSA300_0791 (gcvH) 
      H protein 
     Glycine Cleavage System  SAUSA300_1498 (gcvT) 
      T protein 
      (EC 2.1.2.10) 
     Dihydrolipoamide Dehydrog- SAUSA300_0996 (lpdA) 
      enase 
      (EC 1.8.1.4) 
(3) Serine yielding pyruvate  Serine Dehydratase  SAUSA300_2469 (sdaAA) 
         (EC 4.3.1.7)  SAUSA300_2470 (sdaAB) 
 
Cysteine  (1) Cysteine yielding Alanine  Cysteine Desulferase  SAUSA300_0820 (sufS) 
         (EC 2.8.1.7) 
  
   (2) Alanine yielding pyruvate  Alanine Dehydrogenase  SAUSA300_1331 (ald) 
         (EC 1.4.1.1) 
 
Amino acids yielding 2-oxoglutarate 
Amino acid  Reaction    Enzyme   FPR3757 
Glutamate  (1) Glutamate yielding 2-oxoglutarate Glutamate Dehydrogenase SAUSA300_0861 (gudB) 
         (EC 1.4.1.3) 
 
Glutamine  (1) Glutamine yielding Glutamate Glutamate Synthase  SAUSA300_0445 (gltB) 
         (EC 1.4.1.13)  SAUSA300_0446 (gltD) 
   (2) Glutamate yielding 2-oxoglutarate Glutamate Dehydrogenase SAUSA300_0861 (gudB) 
         (EC 1.4.1.3) 
 
Histidine  (1) Histidine yielding Urocanate  Histidine Ammonia Lyase SAUSA300_0008 (hutH) 
         (EC 4.3.1.3) 
 
   (2) Urocanate yielding 4-imidazolone- Urocanate Hydratase  SAUSA300_2278 (hutU) 
    5-Propanoate    (EC 4.2.1.49) 
 
   (3) 4-imidazolone-5-Propanoate yielding Imidazolone-5-Propanoate SAUSA300_2277 (hutI) 
    N-formimino-L-Glutamate  hydrolase   
         (EC 3.5.2.7) 
 
   (4) N-formimino-L-Glutamate yielding Formiminoglutamate hydrolase SAUSA300_2281 (hutG) 
    Glutamate 
 
   (5) Glutamate yielding 2-oxoglutarate Glutamate Dehydrogenase SAUSA300_0861 (gudB) 
         (EC 1.4.1.3) 
 
Arginine  (1) Arginine yielding Ornithine  Arginase   SAUSA300_2114 (rocF) 
(via arginase)        (EC 3.5.3.1) 
 
   (2) Ornithine yielding Glutamate 5- Ornithine Aminotransferase SAUSA300_0187 (rocD) 
    Semialdehyde/Pyrroline 5-  (EC 2.6.1.13) 
    Carboxylate 
 
   (3) Glutamate 5-Semialdehyde/  Pyrroline 5-Carboxylate  SAUSA300_2491 (rocA) 
    Pyrroline 5-Carboxylate yielding  dehydrogenase 
    Glutamate    (EC 1.5.1.12) 
 
   (4) Glutamate yielding 2-oxoglutarate Glutamate Dehydrogenase SAUSA300_0861 (gudB) 
         (EC 1.4.1.3) 
 
Arginine  (1) Arginine yielding Citrulline  Arginine Deiminase  SAUSA300_2570 (arcA1) 
(via arginine         (EC 3.5.3.6)  SAUSA300_0065 (arcA2) 
deiminase)   
   (2) Citrulline yielding Ornithine  Ornithine Carbamoyl-   SAUSA300_2569 (arcB1) 
         transferase  SAUSA300_0062 (arcB2) 
         (EC 2.1.3.3) 
 
   (3) Ornithine yielding Glutamate 5- Ornithine Aminotransferase SAUSA300_0187 (rocD) 
    Semialdehyde/Pyrroline 5-  (EC 2.6.1.13) 
    Carboxylate 
 
   (4) Glutamate 5-Semialdehyde/  Pyrroline 5-Carboxylate  SAUSA300_2491 (rocA) 
    Pyrroline 5-Carboxylate yielding  dehydrogenase 
    Glutamate    (EC 1.5.1.12) 
 
   (5) Glutamate yielding 2-oxoglutarate Glutamate Dehydrogenase SAUSA300_0861 (gudB) 
         (EC 1.4.1.3) 
 
Proline   (1) Proline yielding Pyrroline 5-Carbox- Proline Dehydrogenase  SAUSA300_1711 (putA) 
    ylate/Glutamate 5-Semialdehyde (EC 1.5.99.8) 
 
   (2) Glutamate 5-Semialdehyde/  Pyrroline 5-Carboxylate  SAUSA300_2491 (rocA) 
    Pyrroline 5-Carboxylate yielding  dehydrogenase 
    Glutamate    (EC 1.5.1.12) 
 
    
(3) Glutamate yielding 2-oxoglutarate Glutamate Dehydrogenase SAUSA300_0861 (gudB) 
         (EC 1.4.1.3) 
 
Amino acids yielding oxaloacetate 
Amino acid  Reaction    Enzyme   FPR3757 
 
Aspartate  (1) Aspartate yielding Oxaloacetate Aspartate Aminotransferase SAUSA300_1916 (aspA) 
         (EC 2.6.1.1) 
 
Asparagine  (1) Asparagine yielding Aspartate Asparaginase   SAUSA300_1368 (ansA) 
         (EC 3.5.1.1) 
 
   (2) Aspartate yielding Oxaloacetate Aspartate Aminotransferase SAUSA300_1916 (aspA) 
         (EC 2.6.1.1) 
 
No catabolic pathway predicted 
Tryptophan 
Isoleucine 
Leucine 
Lysine 
Methionine 
Phenylalanine 
Tyrosine 
Valine 
 
aCatabolic pathways were predicted using BsubCyc and EcoCyc on the MetaCyc server (metacyc.org) and UniProt.  S. 
aureus orthologues were detected using the USA300_FPR3757 genome sequence (CP000255).   
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Name Sequence (5’ to 3’) Target 
2838 GCTTCATCAACATGGCGTAA Forward primer to 
amplify putA 
2839 ATGATGCGATGGTCATGTGT Reverse primer to 
amplify putA 
2840 TTCCACCCAGATGTTGATGA Forward primer to 
amplify gudB 
2841 GGCATTACCGAAACCTTGAA Reverse primer to 
amplify gudB 
2932 GAAGCAGTTGGTGATGCAGC Forward primer to 
amplify rocA 
2933 GCACGTGAACATGCTGAACA Reverse primer to 
amplify rocA 
2034 
 
ATTGATGCAGCACAAGCAAG 
 
Forward primer to 
amplify rocD 
2035 
 
CCGCTGTTAACCAAGGTCAT 
 
Reverse primer to 
amplify rocD 
2836 AGGTACCTGCTGTGAACATTGA 
 
Forward primer to 
amplify rocF 
2837 GAACGCCATCAACATTGCGT Reverse primer to 
amplify rocF 
3100 GGACAGATGACAGCCGGTAG 
 
Forward primer to 
amplify hutU 
3101 AGCCTGGGAAGTCAAAAGCA 
 
Reverse primer to 
amplify hutU 
2344 GGGCCCCTGCAGGCAATGGCACTATTAAAG Forward putA 
contains PstI* 
restriction site 
2345 GGGCCCGGATCCCATTGATTATTGTTCCAGACTCC Reverse putA 
contains BamHI* 
restriction site 
2846 GGCGGCCTGCAGATGACTGAGAACAATAATTT Forward gudB 
contains PstI* 
restriction site 
2848 GGCGGCGGATCCTTATGCCCAACCACGATATGT Reverse gudB 
contains BamHI* 
restriction site 
*Restriction site denoted in italics 
